Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
10.41
+0.80 (8.32%)
At close: Aug 7, 2026, 4:00 PM EDT
10.42
+0.01 (0.10%)
After-hours: Aug 7, 2026, 6:29 PM EDT

Turn Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
310116--
Market Cap Growth
----
Enterprise Value
304.88111.0200
Last Close Price
10.413.94--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PB Ratio
50.6924.75--
P/TBV Ratio
56.7629.01--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.970.01-0.450
Net Debt / Equity Ratio
-0.85-1.074.24-13.48
Net Debt / EBITDA Ratio
0.780.860.430.51
Net Debt / FCF Ratio
1.381.950.550.84
Quick Ratio
2.190.851.232.41
Current Ratio
2.230.871.552.45
Return on Equity (ROE)
-71.02%-141.67%3858.47%-2672.64%
Return on Assets (ROA)
-43.63%-82.45%-88.47%-114.63%
Return on Invested Capital (ROIC)
-94.31%-146.40%-196.57%-275.80%
Return on Capital Employed (ROCE)
-68.32%-156.23%-125.47%-151.47%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-5.93%-4.03%-3.46%-
Total Shareholder Return
-5.93%-4.03%-3.46%-
SEC Filings: 10-K · 10-Q